Foster & Motley »

Silverback Therapeutics shares owned by Foster & Motley

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Foster & Motley from 13F filings

Historical chart of Foster & Motley investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Foster & Motley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Foster & Motley

Quarter filed Position value Share count Share price at filing
2025-09-30 $149k 15k 10.08
2025-06-30 $258k 15k 17.46
2025-03-31 $186k 15k 12.58

More positions owned by Foster & Motley

Schwab Fundamental Intl Lg Co ETF Etf (FNDF)
Janus Henderson Mortgage-Backed ETF Etf (JMBS)
Schwab International Equity ETF Etf (SCHF)
Hartford Multifactor Developed Markets ETF Etf (RODM)
Apple (AAPL)
Schwab Fundamental Emerg Mkts Lg Co ETF Etf (FNDE)
Avantis Emerging Markets Equity ETF Etf (AVEM)
Cambria Emerging Shareholder Yield ETF Etf (EYLD)
Microsoft Corporation (MSFT)
Schwab Intermediate-Term U.S. Trsy ETF Etf (SCHR)
Alphabet Inc Class C cs (GOOG)
Janus Henderson AAA CLO ETF Etf (JAAA)
Vanguard Reit Index ETF Etf (VNQ)
Tortoise North American Pipeline Fund (TPYP)
Schwab US TIPS ETF Etf (SCHP)

View all positions for Foster & Motley

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics